Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.
Cancer Science & Therapy has got h-index 27, which means every article in Cancer Science & Therapy has got 27 average citations.
Following are the list of articles that have cited the articles published in Cancer Science & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
Total published articles |
57 | 46 | 70 | 59 | 42 | 78 | 71 |
Research, Review articles and Editorials |
3 | 4 | 18 | 22 | 27 | 26 | 69 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
41 | 45 | 52 | 37 | 15 | 52 | 2 |
Conference proceedings |
0 | 21 | 45 | 12 | 0 | 162 | 404 |
Citations received as per Google Scholar, other indexing platforms and portals |
4129 | 3358 | 294 | 348 | 345 | 373 | 344 |
| Journal total citations count | 5332 |
| Journal impact factor | 2.06 |
| Journal 5 years impact factor | 2.85 |
| Journal cite score | 6.17 |
| Journal h-index | 27 |
| Journal h-index since 2019 | 18 |
Tocchetti CG, Cadeddu C, Di Lisi D, Femminò S, Madonna R, Mele D, Monte I, Novo G, Penna C, Pepe A, Spallarossa P. From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: a translational overview. Antioxidants & redox signaling. 2017 May 15. |
|
Deidda M, Madonna R, Mango R, Pagliaro P, Bassareo PP, Cugusi L, Romano S, Penco M, Romeo F, Mercuro G. Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection. Journal of Cardiovascular Medicine. 2016 May 1;17(1):S76-83. |
|
Ezquer F, Gutiérrez J, Ezquer M, Caglevic C, Salgado HC, Calligaris SD. Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears. Stem cell research & therapy. 2015 Dec;6(1):116. |
|
Ammar HI, Sequiera GL, Nashed MB, Ammar RI, Gabr HM, Elsayed HE, Sareen N, Abu-El Rub E, Zickri MB, Dhingra S. Comparison of adipose tissue-and bone marrow-derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats. Stem cell research & therapy. 2015 Dec;6(1):148. |
|
Singla DK. Aktâ€ÂmTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity Following Embryonic Stem Cell Transplantation. Cell transplantation. 2015 Jun 23;24(6):1031-42. |
|
Oliveira MS, Carvalho JL, Campos AC, Gomes DA, de Goes AM, Melo MM. Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells. Toxicology letters. 2014 Jan 30;224(3):380-6. |
|
Merino H, Singla DK. Notch-1 mediated cardiac protection following embryonic and induced pluripotent stem cell transplantation in doxorubicin-induced heart failure. PLoS One. 2014 Jul 2;9(7):e101024. |
|
Madonna R, Cadeddu C, Deidda M, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Spallarossa P, Tocchetti CG, Zito C. Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection. Heart failure reviews. 2015 Sep 1;20(5):621-31. |
|
Pecoraro M, Del Pizzo M, Marzocco S, Sorrentino R, Ciccarelli M, Iaccarino G, Pinto A, Popolo A. Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity. Toxicology and applied pharmacology. 2016 Feb 15;293:44-52. |
|
Zhang Y, Liang X, Liao S, Wang W, Wang J, Li X, Ding Y, Liang Y, Gao F, Yang M, Fu Q. Potent paracrine effects of human induced pluripotent stem cell-derived mesenchymal stem cells attenuate doxorubicin-induced cardiomyopathy. Scientific reports. 2015 Jun 9;5:11235. |
|
Manasa P. Epigenetics–Role as Biomarker in Cancer Diagnosis. Adv Oncol Res Treat. 2016;2:r001. |
|
Mir R, Najar IA, Guru S, Javaid J, Yadav P, Masroor M, Zuberi M, Farooq S, Bhat M, Gupta N, Ray PC. A deletion polymorphism in the RIZ gene is associated with increased progression of imatinib treated chronic myeloid leukemia patients. Leukemia & lymphoma. 2017 Jul 3;58(7):1694-701. |
|
Majeed KR. ًﺎﯾرارﺣ ïºâ€Ã¯Â»Å¸Ã™Ë†Ã¯Âºâ€”ﻘﻣﻟا ﺎﯾﻼﺧﻟا مادﺧﺗﺳﺎﺑ ïºâ€Ã¯Â¯Â¾Ã¯Â»Â§Ã¯ÂºÅ½Ã˜Â·Ã˜Â±Ã¯ÂºÂ³Ã¯Â»Å¸Ã˜Â§ ﺎﯾﻼﺧﻟا طﯾﺑﺛﺗ ردﺎﺻﻣ نﻣ ïºâ€Ã¯Â»Å¸Ã™Ë†Ã˜Â²Ã¯Â»Å’ﻣﻟا Lactobacillus plantarum ﺎﯾرﺗï®Âﺑﻟ ïºâ€Ã¯Â»â€Ã¯Â»Å¸Ã¯Âºâ€”ﺧﻣ ïºâ€Ã¯Â¯Â¾Ã¯Âºâ€¹Ã˜Â§Ã˜Â°Ã¯Â»Â. |
|
Selim MS, Amer SK, Mohamed SS, Mounier MM, Rifaat HM. Production and characterisation of exopolysaccharide from Streptomyces carpaticus isolated from marine sediments in Egypt and its effect on breast and colon cell lines. Journal of Genetic Engineering and Biotechnology. 2018 Jun 1;16(1):23-8. |
|
Abdelnasser SM, Yahya SM, Mohamed WF, Asker MM, Shady HM, Mahmoud MG, Gadallah MA. Antitumor Exopolysaccharides Derived from Novel Marine Bacillus: Isolation, Characterization Aspect and Biological Activity. Asian Pacific journal of cancer prevention: APJCP. 2017;18(7):1847. |
|
قيثار رشيد مجيد, ناهييوس٠ياسين, ÙÂاطمة ØÂسنأØÂمد. تثبيط الخلايا السرطانية باستخدام الخلايا المقتولة ØÂرارياً لبكتريا Lactobacillus plantarum المعزولة منمصادر غذائية مختلÙÂØ©. المجلة العراقية للسرطانوالوراثة الطبية. 2015;8(2):198-202. |
|
Vidhyalakshmi R, Valli NC, Kumar GN, Sunkar S. Bacillus circulans exopolysaccharide: Production, characterization and bioactivities. International journal of biological macromolecules. 2016 Jun 1;87:405-14. |
|
Huang X, Borgström B, Stegmayr J, Abassi Y, Kruszyk M, Leffler H, Persson L, Albinsson S, Massoumi R, Scheblykin IG, Hegardt C. The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin. ACS Central Science. 2018 Jun 14. |
|
Mirkheshti N, Park S, Jiang S, Cropper J, Werner SL, Song CS, Chatterjee B. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer. Oncotarget. 2016 Sep 20;7(38):62240. |
|
Kim SH, Kim KY, Yu SN, Park SG, Yu HS, Seo YK, Ahn SC. Monensin induces PC-3 prostate cancer cell apoptosis via ROS production and Ca2+ homeostasis disruption. Anticancer research. 2016 Nov 1;36(11):5835-43. |
|
Cancer Science & Therapy received 5332 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 